SEC Form 4/A · accession 0001192482-19-000123
INTERPACE BIOSCIENCES, INC. · IDXG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
James Early
Officer — Chief Financial Officer
Period of report
Dec 5, 2018
Accepted (ET)
Mar 8, 2019 · 4:16 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001054102
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Dec 5, 2018 | A | 3,000 | — | A | 17,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F3,F4 | $1.08 | Dec 5, 2018 | A | 12,000 | A | — | Dec 5, 2028 | Common Stock | 12,000 | 12,000 | D |
Explanation of responses
- F1On December 6, 2018, the award of restricted stock units was inadvertently omitted from the reporting person's Form 4 filing. The restricted stock units vest annually, in equal installments, over a three-year period, commencing on December 5, 2019.
- F2Each restricted stock unit represents the contingent right to receive one share of common stock of the Issuer.
- F3On December 6, 2018, the award of stock options was inadvertently overstated on the reporting person's Form 4 filing as 15,000 stock options. 12,000 stock options were awarded.
- F4The stock options vest and become exercisable over a three-year period, in equal installments, commencing on December 5, 2019, subject to the reporting person's continued service with the Issuer.